Shock A Clinical Guide to Classification, Stages, and Treatment
Understanding Shock: A Syndrome of Impaired Perfusion
1. Shock Defined: Shock is a critical syndrome characterized by decreased tissue
perfusion and impaired cellular metabolism. This results in an imbalance between the
delivery and utilization of oxygen and nutrients at the cellular level.
2. The Fundamental Imbalance: Shock represents a critical imbalance between the
supply and demand of oxygen and nutrients at the cellular level.
Classifications of Shock
3. Main Classifications: The three primary classifications of shock are:
o Hypovolemic
o Cardiogenic
o Circulatory (Distributive)
Cardiogenic Shock: Pump Failure
4. Pathophysiology: Dysfunction of the heart's pumping action leads to decreased
cardiac output (CO), resulting in cardiogenic shock.
5. Systolic Failure Examples: Conditions causing the heart to inadequately pump blood
forward include:
o Acute Myocardial Infarction (AMI)
o Blunt cardiac injury
o Severe systemic or pulmonary hypertension
6. Diastolic Failure Examples: Conditions preventing the heart from adequately filling
with blood include:
o Cardiac Tamponade
o Cardiomyopathy
7. Structural Failure Examples: Mechanical issues impeding blood flow include:
, o Valvular dysfunction
o Tension pneumothorax
8. Key Signs and Symptoms: The classic triad of cardiogenic shock includes:
o Tachycardia
o Hypotension
o Narrowed pulse pressure
9. Systemic Vascular Resistance (SVR): SVR increases in cardiogenic shock as the body
attempts to compensate for low CO. This increases the heart's oxygen demand.
10. Cardiac Output (CO): CO decreases significantly in cardiogenic shock due to the
impaired pumping function.
11. Additional Signs and Symptoms: Other clinical manifestations of cardiogenic shock
may include:
o Pallor
o Cool, clammy skin
o Cyanosis
12. Treatment Goal: The primary goal of treatment for cardiogenic shock is to restore
blood flow through and to the heart muscle.
13. Drug Therapies: Pharmacological interventions may include:
o Nitrates
o Diuretics
o Vasodilators (with a goal MAP of 60-65 mmHg)
o Beta-blockers (used cautiously)
o Mechanical circulatory support: Intra-Aortic Balloon Pump (IABP), Ventricular
Assist Device (VAD)
14. Nitrates: Function to dilate coronary arteries, improving blood supply to the
myocardium.
15. Diuretics: Help to reduce preload by decreasing circulating volume.
16. Vasodilators: Aim to reduce afterload, decreasing the resistance the heart must pump
against. The goal of vasodilator therapy is typically to maintain a Mean Arterial Pressure
(MAP) of 60-65 mmHg.
Understanding Shock: A Syndrome of Impaired Perfusion
1. Shock Defined: Shock is a critical syndrome characterized by decreased tissue
perfusion and impaired cellular metabolism. This results in an imbalance between the
delivery and utilization of oxygen and nutrients at the cellular level.
2. The Fundamental Imbalance: Shock represents a critical imbalance between the
supply and demand of oxygen and nutrients at the cellular level.
Classifications of Shock
3. Main Classifications: The three primary classifications of shock are:
o Hypovolemic
o Cardiogenic
o Circulatory (Distributive)
Cardiogenic Shock: Pump Failure
4. Pathophysiology: Dysfunction of the heart's pumping action leads to decreased
cardiac output (CO), resulting in cardiogenic shock.
5. Systolic Failure Examples: Conditions causing the heart to inadequately pump blood
forward include:
o Acute Myocardial Infarction (AMI)
o Blunt cardiac injury
o Severe systemic or pulmonary hypertension
6. Diastolic Failure Examples: Conditions preventing the heart from adequately filling
with blood include:
o Cardiac Tamponade
o Cardiomyopathy
7. Structural Failure Examples: Mechanical issues impeding blood flow include:
, o Valvular dysfunction
o Tension pneumothorax
8. Key Signs and Symptoms: The classic triad of cardiogenic shock includes:
o Tachycardia
o Hypotension
o Narrowed pulse pressure
9. Systemic Vascular Resistance (SVR): SVR increases in cardiogenic shock as the body
attempts to compensate for low CO. This increases the heart's oxygen demand.
10. Cardiac Output (CO): CO decreases significantly in cardiogenic shock due to the
impaired pumping function.
11. Additional Signs and Symptoms: Other clinical manifestations of cardiogenic shock
may include:
o Pallor
o Cool, clammy skin
o Cyanosis
12. Treatment Goal: The primary goal of treatment for cardiogenic shock is to restore
blood flow through and to the heart muscle.
13. Drug Therapies: Pharmacological interventions may include:
o Nitrates
o Diuretics
o Vasodilators (with a goal MAP of 60-65 mmHg)
o Beta-blockers (used cautiously)
o Mechanical circulatory support: Intra-Aortic Balloon Pump (IABP), Ventricular
Assist Device (VAD)
14. Nitrates: Function to dilate coronary arteries, improving blood supply to the
myocardium.
15. Diuretics: Help to reduce preload by decreasing circulating volume.
16. Vasodilators: Aim to reduce afterload, decreasing the resistance the heart must pump
against. The goal of vasodilator therapy is typically to maintain a Mean Arterial Pressure
(MAP) of 60-65 mmHg.
